{
    "clinical_study": {
        "@rank": "137856", 
        "acronym": "EPPA", 
        "arm_group": [
            {
                "arm_group_label": "Estradiol Daily", 
                "arm_group_type": "Experimental", 
                "description": "1 mg Estradiol daily for 180 days."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo for 180 days."
            }
        ], 
        "brief_summary": {
            "textblock": "This study aims to determine if hormone replacement therapy, given during perimenopause may\n      prevent the progression of saccular cerebral aneurysms."
        }, 
        "brief_title": "Estrogen Therapy as Prevention in the Progression of Aneurysm (EPPA) Trial", 
        "condition": [
            "Cerebral Aneurysm", 
            "Perimenopause"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Aneurysm", 
                "Intracranial Aneurysm"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a prospective, randomized, placebo-control trial to test the effect of estradiol in\n      the prevention of progression of cerebral aneurysms. To evaluate the effect, each subject\n      will be treated with either oral estradiol or placebo for 6 months.  Subjects will be\n      randomly assigned to 1 of 2 groups as follows:\n\n      Double Blind Treatment Group Open-Label Regimen A1 1 mg  Estradiol daily for 180 days B1\n      Placebo for 180 days\n\n      Each group will be given oral Progesterone (3300 mg) for 10 days at the end of 90 days\n      regardless of menstrual pattern. Subjects will be asked to keep a menstrual calendar\n      throughout the trial. Serum markers will be drawn at baseline and every 90 days with the\n      results blinded until the end of the trial.  Magnetic resonance angiography (MRA) studies of\n      the brain will be performed at month 6."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Generally healthy women, 40-52 years of age.\n\n          -  At least one documented saccular intracranial cerebral aneurysm detected via catheter\n             angiography, magnetic resonance angiography or computed tomography angiography.\n\n          -  Clinical diagnosis of perimenopause, defined as regular or irregular menses with or\n             without vasomotor symptoms.\n\n        Exclusion Criteria:\n\n          -  Known or suspected estrogen-dependent neoplasia.\n\n          -  Endometrial proliferation, hyperplasia, or malignancy at screening.\n\n          -  Known hypersensitivity to estrogens, progestins.\n\n          -  History of myocardial infarction, ischemic heart disease, lipid disorder, or\n             congestive heart failure.\n\n          -  Known or suspected pregnancy, or recent breast feeding (within 6 months)."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "52 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "26", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01895881", 
            "org_study_id": "EPPA - 12101906"
        }, 
        "intervention": [
            {
                "arm_group_label": "Estradiol Daily", 
                "intervention_name": "Estradiol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Estradiol", 
                "Polyestradiol phosphate", 
                "Estrogens", 
                "Estradiol valerate", 
                "Estradiol 3-benzoate", 
                "Estradiol 17 beta-cypionate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Intracranial Aneurysm", 
            "Estradiol"
        ], 
        "lastchanged_date": "January 15, 2014", 
        "link": {
            "description": "Related Info", 
            "url": "http://www.rush.edu/rumc/page-1285684914774.html"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60612"
                }, 
                "name": "Rush University Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "Michael Chen, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Barbara Soltes, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Estrogen Therapy as Prevention in the Progression of Aneurysm", 
        "overall_contact": {
            "email": "Christy_Anton@rush.edu", 
            "last_name": "Christy Anton", 
            "phone": "312-942-1489"
        }, 
        "overall_contact_backup": {
            "email": "Valerie_Toll@rush.edu", 
            "last_name": "Valerie Toll, ACNP", 
            "phone": "312-563-2817"
        }, 
        "overall_official": [
            {
                "affiliation": "Rush University Medical Center", 
                "last_name": "Michael Chen, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Rush University Medical Center", 
                "last_name": "Barbara Soltes, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Parallel design double-blind placebo controlled trial to assess the effect of low dose estradiol on serum lipoprotein (a), serum elastase, and homocysteine.", 
            "measure": "Effect of low dose estradiol on a panel of serum markers.", 
            "safety_issue": "Yes", 
            "time_frame": "Change in levels of serum markers from baseline and six months."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01895881"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rush University Medical Center", 
            "investigator_full_name": "Michael Chen, M.D.", 
            "investigator_title": "Associate Professor of Neurology, Neurosurgery and Radiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": [
            {
                "PMID": "21990811", 
                "citation": "Chen M, Ouyang B, Goldstein-Smith L, Feldman L. Oral contraceptive and hormone replacement therapy in women with cerebral aneurysms. J Neurointerv Surg. 2011 Jun;3(2):163-6. doi: 10.1136/jnis.2010.003855. Epub 2010 Dec 17."
            }, 
            {
                "PMID": "22700728", 
                "citation": "Ding C, Toll V, Ouyang B, Chen M. Younger age of menopause in women with cerebral aneurysms. J Neurointerv Surg. 2013 Jul;5(4):327-31. doi: 10.1136/neurintsurg-2012-010364. Epub 2012 Jun 13."
            }
        ], 
        "secondary_outcome": {
            "measure": "Radiographic change in the cerebral vasculature after treatment.", 
            "safety_issue": "Yes", 
            "time_frame": "From date of randomization to six months."
        }, 
        "source": "Rush University Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "The Brain Aneurysm Foundation", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Rush University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}